nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—POR—urinary bladder cancer	0.478	1	CbGaD
Nitrofurantoin—POR—Mitomycin—urinary bladder cancer	0.337	0.738	CbGbCtD
Nitrofurantoin—POR—Doxorubicin—urinary bladder cancer	0.0472	0.103	CbGbCtD
Nitrofurantoin—ABCG2—Fluorouracil—urinary bladder cancer	0.015	0.033	CbGbCtD
Nitrofurantoin—ABCG2—Carboplatin—urinary bladder cancer	0.0149	0.0328	CbGbCtD
Nitrofurantoin—ABCG2—Cisplatin—urinary bladder cancer	0.0128	0.028	CbGbCtD
Nitrofurantoin—ABCG2—Etoposide—urinary bladder cancer	0.0125	0.0275	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—urinary bladder cancer	0.00856	0.0188	CbGbCtD
Nitrofurantoin—ABCG2—Methotrexate—urinary bladder cancer	0.00829	0.0182	CbGbCtD
Nitrofurantoin—POR—prostate gland—urinary bladder cancer	0.000635	0.205	CbGeAlD
Nitrofurantoin—POR—seminal vesicle—urinary bladder cancer	0.000537	0.174	CbGeAlD
Nitrofurantoin—POR—urethra—urinary bladder cancer	0.000425	0.137	CbGeAlD
Nitrofurantoin—POR—vagina—urinary bladder cancer	0.000313	0.101	CbGeAlD
Nitrofurantoin—ABCG2—prostate gland—urinary bladder cancer	0.000295	0.0953	CbGeAlD
Nitrofurantoin—ABCG2—seminal vesicle—urinary bladder cancer	0.000249	0.0806	CbGeAlD
Nitrofurantoin—POR—lymph node—urinary bladder cancer	0.000203	0.0655	CbGeAlD
Nitrofurantoin—ABCG2—urethra—urinary bladder cancer	0.000197	0.0638	CbGeAlD
Nitrofurantoin—ABCG2—vagina—urinary bladder cancer	0.000146	0.0471	CbGeAlD
Nitrofurantoin—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.00011	0.00176	CcSEcCtD
Nitrofurantoin—Decreased appetite—Thiotepa—urinary bladder cancer	0.00011	0.00176	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00011	0.00176	CcSEcCtD
Nitrofurantoin—Discomfort—Gemcitabine—urinary bladder cancer	0.00011	0.00175	CcSEcCtD
Nitrofurantoin—Malaise—Cisplatin—urinary bladder cancer	0.00011	0.00175	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000109	0.00175	CcSEcCtD
Nitrofurantoin—Myalgia—Fluorouracil—urinary bladder cancer	0.000109	0.00175	CcSEcCtD
Nitrofurantoin—Chest pain—Fluorouracil—urinary bladder cancer	0.000109	0.00175	CcSEcCtD
Nitrofurantoin—Renal impairment—Epirubicin—urinary bladder cancer	0.000109	0.00174	CcSEcCtD
Nitrofurantoin—Leukopenia—Cisplatin—urinary bladder cancer	0.000109	0.00174	CcSEcCtD
Nitrofurantoin—Constipation—Thiotepa—urinary bladder cancer	0.000108	0.00173	CcSEcCtD
Nitrofurantoin—Discomfort—Fluorouracil—urinary bladder cancer	0.000108	0.00173	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000107	0.0017	CcSEcCtD
Nitrofurantoin—Confusional state—Fluorouracil—urinary bladder cancer	0.000106	0.00169	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000105	0.00167	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000104	0.00167	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000104	0.00167	CcSEcCtD
Nitrofurantoin—Myalgia—Cisplatin—urinary bladder cancer	0.000104	0.00166	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000104	0.00165	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000103	0.00165	CcSEcCtD
Nitrofurantoin—Anaemia—Etoposide—urinary bladder cancer	0.000103	0.00165	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000103	0.00164	CcSEcCtD
Nitrofurantoin—Discomfort—Cisplatin—urinary bladder cancer	0.000102	0.00164	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000102	0.00163	CcSEcCtD
Nitrofurantoin—Anorexia—Gemcitabine—urinary bladder cancer	0.000102	0.00162	CcSEcCtD
Nitrofurantoin—Renal impairment—Doxorubicin—urinary bladder cancer	0.000101	0.00161	CcSEcCtD
Nitrofurantoin—Malaise—Etoposide—urinary bladder cancer	0.000101	0.00161	CcSEcCtD
Nitrofurantoin—Vertigo—Etoposide—urinary bladder cancer	0.0001	0.0016	CcSEcCtD
Nitrofurantoin—Body temperature increased—Thiotepa—urinary bladder cancer	0.0001	0.0016	CcSEcCtD
Nitrofurantoin—Abdominal pain—Thiotepa—urinary bladder cancer	0.0001	0.0016	CcSEcCtD
Nitrofurantoin—Anorexia—Fluorouracil—urinary bladder cancer	9.99e-05	0.0016	CcSEcCtD
Nitrofurantoin—Leukopenia—Etoposide—urinary bladder cancer	9.98e-05	0.00159	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Cisplatin—urinary bladder cancer	9.93e-05	0.00159	CcSEcCtD
Nitrofurantoin—Cough—Etoposide—urinary bladder cancer	9.73e-05	0.00155	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Cisplatin—urinary bladder cancer	9.73e-05	0.00155	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	9.71e-05	0.00155	CcSEcCtD
Nitrofurantoin—Asthma—Methotrexate—urinary bladder cancer	9.58e-05	0.00153	CcSEcCtD
Nitrofurantoin—Paraesthesia—Gemcitabine—urinary bladder cancer	9.57e-05	0.00153	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	9.55e-05	0.00152	CcSEcCtD
Nitrofurantoin—Dyspnoea—Gemcitabine—urinary bladder cancer	9.5e-05	0.00152	CcSEcCtD
Nitrofurantoin—Chest pain—Etoposide—urinary bladder cancer	9.49e-05	0.00152	CcSEcCtD
Nitrofurantoin—Eosinophilia—Methotrexate—urinary bladder cancer	9.49e-05	0.00152	CcSEcCtD
Nitrofurantoin—Somnolence—Gemcitabine—urinary bladder cancer	9.47e-05	0.00151	CcSEcCtD
Nitrofurantoin—Anorexia—Cisplatin—urinary bladder cancer	9.47e-05	0.00151	CcSEcCtD
Nitrofurantoin—ABCG2—lymph node—urinary bladder cancer	9.42e-05	0.0304	CbGeAlD
Nitrofurantoin—Paraesthesia—Fluorouracil—urinary bladder cancer	9.41e-05	0.0015	CcSEcCtD
Nitrofurantoin—Discomfort—Etoposide—urinary bladder cancer	9.38e-05	0.0015	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	9.35e-05	0.00149	CcSEcCtD
Nitrofurantoin—Dyspnoea—Fluorouracil—urinary bladder cancer	9.34e-05	0.00149	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Thiotepa—urinary bladder cancer	9.33e-05	0.00149	CcSEcCtD
Nitrofurantoin—Somnolence—Fluorouracil—urinary bladder cancer	9.31e-05	0.00149	CcSEcCtD
Nitrofurantoin—Decreased appetite—Gemcitabine—urinary bladder cancer	9.26e-05	0.00148	CcSEcCtD
Nitrofurantoin—Dyspepsia—Fluorouracil—urinary bladder cancer	9.22e-05	0.00147	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	9.2e-05	0.00147	CcSEcCtD
Nitrofurantoin—Confusional state—Etoposide—urinary bladder cancer	9.18e-05	0.00147	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	9.15e-05	0.00146	CcSEcCtD
Nitrofurantoin—Constipation—Gemcitabine—urinary bladder cancer	9.11e-05	0.00146	CcSEcCtD
Nitrofurantoin—Decreased appetite—Fluorouracil—urinary bladder cancer	9.11e-05	0.00145	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Etoposide—urinary bladder cancer	9.1e-05	0.00145	CcSEcCtD
Nitrofurantoin—Asthenia—Thiotepa—urinary bladder cancer	9.09e-05	0.00145	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	9.05e-05	0.00145	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	9.05e-05	0.00144	CcSEcCtD
Nitrofurantoin—Asthma—Epirubicin—urinary bladder cancer	8.97e-05	0.00143	CcSEcCtD
Nitrofurantoin—Paraesthesia—Cisplatin—urinary bladder cancer	8.92e-05	0.00142	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Etoposide—urinary bladder cancer	8.91e-05	0.00142	CcSEcCtD
Nitrofurantoin—Eosinophilia—Epirubicin—urinary bladder cancer	8.88e-05	0.00142	CcSEcCtD
Nitrofurantoin—Dyspnoea—Cisplatin—urinary bladder cancer	8.86e-05	0.00141	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Gemcitabine—urinary bladder cancer	8.78e-05	0.0014	CcSEcCtD
Nitrofurantoin—Anorexia—Etoposide—urinary bladder cancer	8.67e-05	0.00139	CcSEcCtD
Nitrofurantoin—Diarrhoea—Thiotepa—urinary bladder cancer	8.67e-05	0.00138	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	8.65e-05	0.00138	CcSEcCtD
Nitrofurantoin—Decreased appetite—Cisplatin—urinary bladder cancer	8.63e-05	0.00138	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Fluorouracil—urinary bladder cancer	8.63e-05	0.00138	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	8.58e-05	0.00137	CcSEcCtD
Nitrofurantoin—Drowsiness—Methotrexate—urinary bladder cancer	8.55e-05	0.00137	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	8.47e-05	0.00135	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	8.47e-05	0.00135	CcSEcCtD
Nitrofurantoin—Body temperature increased—Gemcitabine—urinary bladder cancer	8.42e-05	0.00135	CcSEcCtD
Nitrofurantoin—Renal failure—Methotrexate—urinary bladder cancer	8.4e-05	0.00134	CcSEcCtD
Nitrofurantoin—Dizziness—Thiotepa—urinary bladder cancer	8.38e-05	0.00134	CcSEcCtD
Nitrofurantoin—Asthma—Doxorubicin—urinary bladder cancer	8.3e-05	0.00133	CcSEcCtD
Nitrofurantoin—Body temperature increased—Fluorouracil—urinary bladder cancer	8.28e-05	0.00132	CcSEcCtD
Nitrofurantoin—Eosinophilia—Doxorubicin—urinary bladder cancer	8.22e-05	0.00131	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Cisplatin—urinary bladder cancer	8.19e-05	0.00131	CcSEcCtD
Nitrofurantoin—Paraesthesia—Etoposide—urinary bladder cancer	8.17e-05	0.00131	CcSEcCtD
Nitrofurantoin—Dyspnoea—Etoposide—urinary bladder cancer	8.11e-05	0.0013	CcSEcCtD
Nitrofurantoin—Somnolence—Etoposide—urinary bladder cancer	8.09e-05	0.00129	CcSEcCtD
Nitrofurantoin—Vomiting—Thiotepa—urinary bladder cancer	8.05e-05	0.00129	CcSEcCtD
Nitrofurantoin—Drowsiness—Epirubicin—urinary bladder cancer	8e-05	0.00128	CcSEcCtD
Nitrofurantoin—Rash—Thiotepa—urinary bladder cancer	7.99e-05	0.00128	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Methotrexate—urinary bladder cancer	7.98e-05	0.00127	CcSEcCtD
Nitrofurantoin—Headache—Thiotepa—urinary bladder cancer	7.94e-05	0.00127	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	7.93e-05	0.00127	CcSEcCtD
Nitrofurantoin—Decreased appetite—Etoposide—urinary bladder cancer	7.91e-05	0.00126	CcSEcCtD
Nitrofurantoin—Renal failure—Epirubicin—urinary bladder cancer	7.86e-05	0.00126	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	7.86e-05	0.00125	CcSEcCtD
Nitrofurantoin—Body temperature increased—Cisplatin—urinary bladder cancer	7.85e-05	0.00125	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	7.84e-05	0.00125	CcSEcCtD
Nitrofurantoin—Constipation—Etoposide—urinary bladder cancer	7.78e-05	0.00124	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Fluorouracil—urinary bladder cancer	7.72e-05	0.00123	CcSEcCtD
Nitrofurantoin—Hepatitis—Methotrexate—urinary bladder cancer	7.67e-05	0.00123	CcSEcCtD
Nitrofurantoin—Asthenia—Gemcitabine—urinary bladder cancer	7.65e-05	0.00122	CcSEcCtD
Nitrofurantoin—Nausea—Thiotepa—urinary bladder cancer	7.52e-05	0.0012	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Etoposide—urinary bladder cancer	7.5e-05	0.0012	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Epirubicin—urinary bladder cancer	7.46e-05	0.00119	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Etoposide—urinary bladder cancer	7.44e-05	0.00119	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—urinary bladder cancer	7.4e-05	0.00118	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	7.34e-05	0.00117	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Cisplatin—urinary bladder cancer	7.32e-05	0.00117	CcSEcCtD
Nitrofurantoin—Diarrhoea—Gemcitabine—urinary bladder cancer	7.29e-05	0.00116	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—urinary bladder cancer	7.27e-05	0.00116	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Methotrexate—urinary bladder cancer	7.25e-05	0.00116	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	7.25e-05	0.00116	CcSEcCtD
Nitrofurantoin—Abdominal pain—Etoposide—urinary bladder cancer	7.19e-05	0.00115	CcSEcCtD
Nitrofurantoin—Body temperature increased—Etoposide—urinary bladder cancer	7.19e-05	0.00115	CcSEcCtD
Nitrofurantoin—Hepatitis—Epirubicin—urinary bladder cancer	7.18e-05	0.00115	CcSEcCtD
Nitrofurantoin—Diarrhoea—Fluorouracil—urinary bladder cancer	7.17e-05	0.00115	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Epirubicin—urinary bladder cancer	7.14e-05	0.00114	CcSEcCtD
Nitrofurantoin—Asthenia—Cisplatin—urinary bladder cancer	7.13e-05	0.00114	CcSEcCtD
Nitrofurantoin—Dizziness—Fluorouracil—urinary bladder cancer	6.93e-05	0.00111	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Doxorubicin—urinary bladder cancer	6.91e-05	0.0011	CcSEcCtD
Nitrofurantoin—Chills—Methotrexate—urinary bladder cancer	6.88e-05	0.0011	CcSEcCtD
Nitrofurantoin—Diarrhoea—Cisplatin—urinary bladder cancer	6.8e-05	0.00109	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Epirubicin—urinary bladder cancer	6.79e-05	0.00108	CcSEcCtD
Nitrofurantoin—Alopecia—Methotrexate—urinary bladder cancer	6.78e-05	0.00108	CcSEcCtD
Nitrofurantoin—Vomiting—Gemcitabine—urinary bladder cancer	6.78e-05	0.00108	CcSEcCtD
Nitrofurantoin—Rash—Gemcitabine—urinary bladder cancer	6.72e-05	0.00107	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Etoposide—urinary bladder cancer	6.7e-05	0.00107	CcSEcCtD
Nitrofurantoin—Headache—Gemcitabine—urinary bladder cancer	6.68e-05	0.00107	CcSEcCtD
Nitrofurantoin—Vomiting—Fluorouracil—urinary bladder cancer	6.66e-05	0.00106	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—urinary bladder cancer	6.64e-05	0.00106	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	6.61e-05	0.00106	CcSEcCtD
Nitrofurantoin—Rash—Fluorouracil—urinary bladder cancer	6.61e-05	0.00106	CcSEcCtD
Nitrofurantoin—Headache—Fluorouracil—urinary bladder cancer	6.56e-05	0.00105	CcSEcCtD
Nitrofurantoin—Asthenia—Etoposide—urinary bladder cancer	6.53e-05	0.00104	CcSEcCtD
Nitrofurantoin—Chills—Epirubicin—urinary bladder cancer	6.44e-05	0.00103	CcSEcCtD
Nitrofurantoin—Alopecia—Epirubicin—urinary bladder cancer	6.34e-05	0.00101	CcSEcCtD
Nitrofurantoin—Nausea—Gemcitabine—urinary bladder cancer	6.33e-05	0.00101	CcSEcCtD
Nitrofurantoin—Vomiting—Cisplatin—urinary bladder cancer	6.32e-05	0.00101	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—urinary bladder cancer	6.28e-05	0.001	CcSEcCtD
Nitrofurantoin—Rash—Cisplatin—urinary bladder cancer	6.26e-05	0.001	CcSEcCtD
Nitrofurantoin—Diarrhoea—Etoposide—urinary bladder cancer	6.23e-05	0.000995	CcSEcCtD
Nitrofurantoin—Nausea—Fluorouracil—urinary bladder cancer	6.22e-05	0.000994	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Methotrexate—urinary bladder cancer	6.2e-05	0.00099	CcSEcCtD
Nitrofurantoin—Anaemia—Methotrexate—urinary bladder cancer	6.17e-05	0.000986	CcSEcCtD
Nitrofurantoin—Flatulence—Epirubicin—urinary bladder cancer	6.16e-05	0.000984	CcSEcCtD
Nitrofurantoin—Malaise—Methotrexate—urinary bladder cancer	6.02e-05	0.000962	CcSEcCtD
Nitrofurantoin—Dizziness—Etoposide—urinary bladder cancer	6.02e-05	0.000961	CcSEcCtD
Nitrofurantoin—Vertigo—Methotrexate—urinary bladder cancer	6e-05	0.000958	CcSEcCtD
Nitrofurantoin—Leukopenia—Methotrexate—urinary bladder cancer	5.98e-05	0.000955	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—urinary bladder cancer	5.96e-05	0.000952	CcSEcCtD
Nitrofurantoin—Nausea—Cisplatin—urinary bladder cancer	5.9e-05	0.000942	CcSEcCtD
Nitrofurantoin—Alopecia—Doxorubicin—urinary bladder cancer	5.87e-05	0.000938	CcSEcCtD
Nitrofurantoin—Cough—Methotrexate—urinary bladder cancer	5.83e-05	0.000931	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Epirubicin—urinary bladder cancer	5.8e-05	0.000926	CcSEcCtD
Nitrofurantoin—Vomiting—Etoposide—urinary bladder cancer	5.79e-05	0.000924	CcSEcCtD
Nitrofurantoin—Anaemia—Epirubicin—urinary bladder cancer	5.78e-05	0.000923	CcSEcCtD
Nitrofurantoin—Rash—Etoposide—urinary bladder cancer	5.74e-05	0.000917	CcSEcCtD
Nitrofurantoin—Headache—Etoposide—urinary bladder cancer	5.7e-05	0.000911	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—urinary bladder cancer	5.7e-05	0.00091	CcSEcCtD
Nitrofurantoin—Chest pain—Methotrexate—urinary bladder cancer	5.69e-05	0.000908	CcSEcCtD
Nitrofurantoin—Myalgia—Methotrexate—urinary bladder cancer	5.69e-05	0.000908	CcSEcCtD
Nitrofurantoin—Malaise—Epirubicin—urinary bladder cancer	5.64e-05	0.0009	CcSEcCtD
Nitrofurantoin—Discomfort—Methotrexate—urinary bladder cancer	5.62e-05	0.000897	CcSEcCtD
Nitrofurantoin—Vertigo—Epirubicin—urinary bladder cancer	5.62e-05	0.000897	CcSEcCtD
Nitrofurantoin—Leukopenia—Epirubicin—urinary bladder cancer	5.59e-05	0.000894	CcSEcCtD
Nitrofurantoin—Confusional state—Methotrexate—urinary bladder cancer	5.5e-05	0.000878	CcSEcCtD
Nitrofurantoin—Cough—Epirubicin—urinary bladder cancer	5.45e-05	0.000871	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Methotrexate—urinary bladder cancer	5.45e-05	0.000871	CcSEcCtD
Nitrofurantoin—Nausea—Etoposide—urinary bladder cancer	5.41e-05	0.000863	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	5.37e-05	0.000857	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—urinary bladder cancer	5.34e-05	0.000854	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Methotrexate—urinary bladder cancer	5.34e-05	0.000852	CcSEcCtD
Nitrofurantoin—Chest pain—Epirubicin—urinary bladder cancer	5.32e-05	0.00085	CcSEcCtD
Nitrofurantoin—Myalgia—Epirubicin—urinary bladder cancer	5.32e-05	0.00085	CcSEcCtD
Nitrofurantoin—Discomfort—Epirubicin—urinary bladder cancer	5.26e-05	0.00084	CcSEcCtD
Nitrofurantoin—Malaise—Doxorubicin—urinary bladder cancer	5.21e-05	0.000833	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—urinary bladder cancer	5.2e-05	0.00083	CcSEcCtD
Nitrofurantoin—Anorexia—Methotrexate—urinary bladder cancer	5.2e-05	0.00083	CcSEcCtD
Nitrofurantoin—Leukopenia—Doxorubicin—urinary bladder cancer	5.18e-05	0.000827	CcSEcCtD
Nitrofurantoin—Confusional state—Epirubicin—urinary bladder cancer	5.14e-05	0.000822	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Epirubicin—urinary bladder cancer	5.1e-05	0.000815	CcSEcCtD
Nitrofurantoin—Cough—Doxorubicin—urinary bladder cancer	5.05e-05	0.000806	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.99e-05	0.000798	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	4.97e-05	0.000793	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—urinary bladder cancer	4.92e-05	0.000786	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—urinary bladder cancer	4.92e-05	0.000786	CcSEcCtD
Nitrofurantoin—Paraesthesia—Methotrexate—urinary bladder cancer	4.89e-05	0.000782	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—urinary bladder cancer	4.86e-05	0.000777	CcSEcCtD
Nitrofurantoin—Anorexia—Epirubicin—urinary bladder cancer	4.86e-05	0.000777	CcSEcCtD
Nitrofurantoin—Dyspnoea—Methotrexate—urinary bladder cancer	4.86e-05	0.000776	CcSEcCtD
Nitrofurantoin—Somnolence—Methotrexate—urinary bladder cancer	4.85e-05	0.000774	CcSEcCtD
Nitrofurantoin—Dyspepsia—Methotrexate—urinary bladder cancer	4.8e-05	0.000766	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—urinary bladder cancer	4.76e-05	0.00076	CcSEcCtD
Nitrofurantoin—Decreased appetite—Methotrexate—urinary bladder cancer	4.74e-05	0.000757	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	4.72e-05	0.000754	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	4.71e-05	0.000752	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	4.65e-05	0.000742	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	4.62e-05	0.000738	CcSEcCtD
Nitrofurantoin—Paraesthesia—Epirubicin—urinary bladder cancer	4.58e-05	0.000732	CcSEcCtD
Nitrofurantoin—Dyspnoea—Epirubicin—urinary bladder cancer	4.55e-05	0.000726	CcSEcCtD
Nitrofurantoin—Somnolence—Epirubicin—urinary bladder cancer	4.53e-05	0.000724	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—urinary bladder cancer	4.5e-05	0.000719	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Methotrexate—urinary bladder cancer	4.49e-05	0.000717	CcSEcCtD
Nitrofurantoin—Dyspepsia—Epirubicin—urinary bladder cancer	4.49e-05	0.000717	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	4.46e-05	0.000712	CcSEcCtD
Nitrofurantoin—Decreased appetite—Epirubicin—urinary bladder cancer	4.43e-05	0.000708	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	4.4e-05	0.000703	CcSEcCtD
Nitrofurantoin—Constipation—Epirubicin—urinary bladder cancer	4.36e-05	0.000697	CcSEcCtD
Nitrofurantoin—Abdominal pain—Methotrexate—urinary bladder cancer	4.31e-05	0.000688	CcSEcCtD
Nitrofurantoin—Body temperature increased—Methotrexate—urinary bladder cancer	4.31e-05	0.000688	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	4.3e-05	0.000687	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—urinary bladder cancer	4.24e-05	0.000677	CcSEcCtD
Nitrofurantoin—Dyspnoea—Doxorubicin—urinary bladder cancer	4.21e-05	0.000672	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Epirubicin—urinary bladder cancer	4.2e-05	0.000671	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—urinary bladder cancer	4.2e-05	0.00067	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	4.17e-05	0.000666	CcSEcCtD
Nitrofurantoin—Dyspepsia—Doxorubicin—urinary bladder cancer	4.15e-05	0.000664	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—urinary bladder cancer	4.1e-05	0.000655	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	4.07e-05	0.000651	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—urinary bladder cancer	4.04e-05	0.000645	CcSEcCtD
Nitrofurantoin—Abdominal pain—Epirubicin—urinary bladder cancer	4.03e-05	0.000644	CcSEcCtD
Nitrofurantoin—Body temperature increased—Epirubicin—urinary bladder cancer	4.03e-05	0.000644	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Methotrexate—urinary bladder cancer	4.02e-05	0.000641	CcSEcCtD
Nitrofurantoin—Asthenia—Methotrexate—urinary bladder cancer	3.91e-05	0.000625	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.89e-05	0.000621	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3.86e-05	0.000616	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Epirubicin—urinary bladder cancer	3.76e-05	0.0006	CcSEcCtD
Nitrofurantoin—Body temperature increased—Doxorubicin—urinary bladder cancer	3.73e-05	0.000596	CcSEcCtD
Nitrofurantoin—Abdominal pain—Doxorubicin—urinary bladder cancer	3.73e-05	0.000596	CcSEcCtD
Nitrofurantoin—Diarrhoea—Methotrexate—urinary bladder cancer	3.73e-05	0.000596	CcSEcCtD
Nitrofurantoin—Asthenia—Epirubicin—urinary bladder cancer	3.66e-05	0.000585	CcSEcCtD
Nitrofurantoin—Dizziness—Methotrexate—urinary bladder cancer	3.6e-05	0.000576	CcSEcCtD
Nitrofurantoin—Diarrhoea—Epirubicin—urinary bladder cancer	3.49e-05	0.000557	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Doxorubicin—urinary bladder cancer	3.48e-05	0.000555	CcSEcCtD
Nitrofurantoin—Vomiting—Methotrexate—urinary bladder cancer	3.47e-05	0.000554	CcSEcCtD
Nitrofurantoin—Rash—Methotrexate—urinary bladder cancer	3.44e-05	0.000549	CcSEcCtD
Nitrofurantoin—Headache—Methotrexate—urinary bladder cancer	3.41e-05	0.000545	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—urinary bladder cancer	3.39e-05	0.000541	CcSEcCtD
Nitrofurantoin—Dizziness—Epirubicin—urinary bladder cancer	3.37e-05	0.000539	CcSEcCtD
Nitrofurantoin—Vomiting—Epirubicin—urinary bladder cancer	3.24e-05	0.000518	CcSEcCtD
Nitrofurantoin—Nausea—Methotrexate—urinary bladder cancer	3.24e-05	0.000517	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—urinary bladder cancer	3.23e-05	0.000516	CcSEcCtD
Nitrofurantoin—Rash—Epirubicin—urinary bladder cancer	3.22e-05	0.000514	CcSEcCtD
Nitrofurantoin—Headache—Epirubicin—urinary bladder cancer	3.2e-05	0.00051	CcSEcCtD
Nitrofurantoin—Dizziness—Doxorubicin—urinary bladder cancer	3.12e-05	0.000499	CcSEcCtD
Nitrofurantoin—Nausea—Epirubicin—urinary bladder cancer	3.03e-05	0.000484	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—urinary bladder cancer	3e-05	0.000479	CcSEcCtD
Nitrofurantoin—Rash—Doxorubicin—urinary bladder cancer	2.98e-05	0.000475	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—urinary bladder cancer	2.96e-05	0.000472	CcSEcCtD
Nitrofurantoin—Nausea—Doxorubicin—urinary bladder cancer	2.8e-05	0.000448	CcSEcCtD
